According to Sundar Pichai, the C2S-Scale 27B foundation model, built with Yale and based on Gemma, generated a novel hypothesis about cancer cellular behavior that scientists validated in living cells. Source: Sundar Pichai on X, Oct 15, 2025. Pichai noted more preclinical and clinical tests are needed and the discovery may reveal a new pathway for developing therapies. Source: Sundar Pichai on X, Oct 15, 2025. For traders, this milestone is a headline event for AI-focused equities and AI-linked crypto narratives, but the post contains no mention of cryptocurrencies, tokens, commercialization timelines, or financial guidance. Source: Sundar Pichai on X, Oct 15, 2025.